Skip to main content

Posts

Showing posts from March, 2026

Research Associate vs QA/QC vs Bioprocess: Which Entry-Level Role Fits You?

 Research Associate vs QA/QC vs Bioprocess: Which Entry-Level Role Fits You? Not sure which biotech entry-level role fits your strengths? You’re not alone. Many science grads feel stuck between lab discovery, manufacturing scale-up, and quality compliance. The wrong fit leads to burnout, boredom, or slow growth. I’ve helped hundreds of new biotech professionals choose their first role over 20+ years. The right fit depends on your work style, not just your degree. Some people thrive on experiments. Others love machines. Some prefer checklists and rules. In this guide, you’ll learn what each role does day to day, what skills you need, and how to break into the Florida biotech job market fast. You’ll see real salary ranges, career paths, and resume tips that actually work. By the end, you’ll know exactly which path matches your goals. Quick Answer Choose Research Associate if you love experiments and discovery. Pick Bioprocess if you enjoy hands-on manufacturing and shift work. Sel...

NC biotech center

 NC biotech center In 1981, a group of North Carolina legislators sat down to wrestle with a question that sounds almost naïve in retrospect: how do you build an industry that doesn't exist yet? The field of biotechnology was still largely theoretical — more petri dish than product line — and most American policymakers were content to watch the coastal research universities and their adjacent venture capital ecosystems take the lead. North Carolina's legislators took a different view. After commissioning a year-long study, they landed on an answer that was, frankly, unusual for the era: create a private, non-profit organization whose sole purpose was to grow biotechnology in the state. Not a government bureau. Not a university department. Something in between, and deliberately so. Three years later, in October 1984, the North Carolina Biotechnology Center (NCBiotech) opened in Research Triangle Park. It was, by most accounts, the world's first government-sponsored biotec...

RBC Biotech Industry Primer: What Wall Street Isn’t Telling You About Biotech in 2026

 RBC Biotech Industry Primer: What Wall Street Isn’t Telling You About Biotech in 2026 There is a reason biotech remains one of the most watched — and most misunderstood — corners of the financial markets. A company with no revenue, no approved products, and a team of fifty scientists can command a billion-dollar valuation. A single clinical trial result, announced before the market opens on a Tuesday morning, can either double that valuation or wipe out most of it by the afternoon close. No other sector quite works this way. For investors trying to make sense of it, the learning curve is steep. The science is technical. The regulatory environment is layered and constantly evolving. The financial metrics are unlike anything taught in a standard accounting course. And the competitive dynamics shift fast — a platform that looks dominant today can be rendered obsolete by a rival's data package in a matter of months. That is precisely why documents like the RBC Biotech Industry Prim...